We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




POC Sepsis Detection Software Provides Clinicians with Early Warning of Patient Deterioration in ICU

By HospiMedica International staff writers
Posted on 26 Aug 2024
Print article
Image: The NAVOY algorithm assists in predicting ICU patients’ risk of developing sepsis (Photo courtesy of AlgoDx)
Image: The NAVOY algorithm assists in predicting ICU patients’ risk of developing sepsis (Photo courtesy of AlgoDx)

Sepsis, a severe reaction to infection causing widespread inflammation, can rapidly lead to organ damage and death, making it the primary cause of mortality within hospitals globally, contributing to around 35% of all hospital deaths. The key to combating sepsis lies in its early detection and prompt treatment. Although intensive care units (ICUs) generate vast amounts of data, which can make it difficult to spot some signs of patient deterioration in time, these environments are ideally suited for the application of artificial intelligence (AI) technologies. Now, an AI solution offers the potential to improve sepsis care by providing healthcare providers with a powerful tool to identify patients at risk in the Emergency Department (ED) as well as other hospital wards.

AlgoDx (Stockholm, Sweden) has introduced NAVOY CDS, a sepsis detection software using a proprietary algorithm, to support clinicians in identifying sepsis in hospitalized patients, including the ED. Utilizing a machine learning algorithm trained on data from over 60,000 ICU stays, NAVOY can predict the risk of sepsis up to three hours before traditional rule-based scoring systems, thereby facilitating earlier and more accurate clinical responses that can save lives and reduce healthcare expenses.

As a software as a medical device (SaMD), NAVOY continuously analyzes a range of vital signs, lab results, and other critical patient data gathered in the ICU, integrating seamlessly into existing Electronic Health Records (EHR) and Patient Data Management Systems (PDMS). This integration ensures that NAVOY’s predictions are readily accessible, providing clinicians with timely, actionable insights that enable swift interventions. With the latest U.S. Food and Drug Administration’s (FDA) 510(k) clearance, AlgoDx is set to extend its reach into the U.S. healthcare market, offering a significant advancement in the fight against hospital-acquired sepsis.

“Receiving FDA clearance for NAVOY CDS is a testament to our team’s dedication and expertise in developing cutting-edge medical device software for healthcare,” said Andreas Macura, Chief Product Officer at AlgoDx. “We believe that NAVOY CDS has the potential to significantly improve patient outcomes by enabling earlier detection and treatment of sepsis.”

“This FDA clearance is a pivotal moment for AlgoDx as we expand our presence in the United States,” added Dr. Enrico Petrillo, Chairman of the Board AlgoDx. “It validates our commitment to developing innovative technologies that address critical healthcare challenges. We look forward to bringing NAVOY CDS to health systems nationwide.”

Related Links:
AlgoDx

Gold Member
12-Channel ECG
CM1200B
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Countertop Blanket Warmer
DC400
New
Silver Member
Advanced 12-Lead Electrocardiograph with Printer
NECG SE-1200 Pro

Print article
Radcal

Channels

Surgical Techniques

view channel
Image: Researchers conducted an electric surgical procedure on a bile duct obstruction experimentally with a robotic convoy (Photo courtesy of DKFZ)

Miniature Robots Transport Instruments for Endoscopic Microsurgery Through Body

The potential applications for miniature robots in medicine are vast, ranging from targeted drug delivery to diagnostic tasks and performing surgical procedures. Researchers have already developed and... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.